Graft Polymer (UK) PLC (GB:GPL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Graft Polymer (UK) PLC has achieved significant milestones in its joint venture with Awakn Life Sciences Corp., including identifying promising new compounds for treating trauma-related disorders like PTSD, establishing efficient synthesis pathways, and filing a provisional patent. Partnering with Charnwood Discovery for synthesis services, the collaboration aims to advance these novel therapeutics towards the market, signaling a major step forward in the development of new treatments for mental health disorders.
For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.
